← Leaderboards
Alexander V Statsyuk
Northwestern University
$1,902,692
Attributed
$1,902,692
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $302.2K · FY2015–23$500K$375K$250K$125K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,902,692 · 2
By mechanism
R01$1,483,386 · 1
R21$419,306 · 1
Top collaborators
No co-investigators on record.
Most similar at Northwestern University
Same institution · by research overlap
- Linda A. Hicke$4,096,111
- Derek Walsh$9,010,067
- Mojgan Hosseini Naghavi$10,646,982
- Laimonis A Laimins$22,555,906
- Arthur Veis$6,059,402
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsCovalent BondSurfaceStructure-Activity RelationshipDrug DiscoveryProgramsInsulinPharmaceutical PreparationsProteinsSmall MoleculeTechnologyAnalogBiologyPublic Health RelevanceCysteineHuman DiseaseBasePharmacologyCell ProliferationBeta CellEndocytosisCancer CellBasic ScienceEnzyme Inhibitor Drugs
Grant awards (8)
Chemical platform to produce covalent biologics$183,405
R21 · FY2023 · GM · contact PI
Chemical platform to produce covalent biologics$235,901
R21 · FY2022 · GM · contact PI
Pharmacological Inhibitors of Nedd4 ubiquitin ligase as anticancer therapeutics$302,175
R01 · FY2019 · GM · contact PI
Pharmacological Inhibitors of Nedd4 ubiquitin ligase as anticancer therapeutics$302,175
R01 · FY2018 · GM · contact PI
Pharmacological Inhibitors of Nedd4 ubiquitin ligase as anticancer therapeutics$301,352
R01 · FY2017 · GM · contact PI
Pharmacological Inhibitors of Nedd4 ubiquitin ligase as anticancer therapeutics$265,851
R01 · FY2016 · GM · contact PI
Pharmacological Inhibitors of Nedd4 ubiquitin ligase as anticancer therapeutics$24,085
R01 · FY2016 · GM · contact PI
Pharmacological Inhibitors of Nedd4 ubiquitin ligase as anticancer therapeutics$287,748
R01 · FY2015 · GM · contact PI